Panel Discussion | Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

Monday, March 10, 2025

11:59 AM – 12:25 PM ET

Panel Moderator(s)

Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure information not submitted.
Yoshinobu Onuma, MD, PhD

Professor of Interventional Cardiology
University of Galway
Galway, Galway, Ireland

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Andreas Baumbach, MD, FRCP, FESC

Chair
Queen Mary University of London
London, England, United Kingdom

Disclosure information not submitted.
Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

Disclosure(s): No financial relationships to disclose
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Disclosure(s): CoreAalst: Consulting Fees (e.g., advisory boards) (Ongoing), Executive Board (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Cezar A. Iliescu, MD

Medical Director MD Anderson Cardiac Catheterization Laboratory
The University of Texas MD Anderson Cancer Center, Texas, United States

Disclosure(s): No financial relationships to disclose
Sahil A. Parikh, MD, FSCAI

Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States

Disclosure information not submitted.
Richard J. Rapoza, PhD

Divisional Vice President, Global Research and Development
Abbott Vascular
Santa Clara, California, United States

Disclosure information not submitted.
Pieter C. Smits, PhD, FESC

Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands

Disclosure information not submitted.
Jean-Francois Tanguay, MD

Full professor of Medicine, Director, Interventional Cardiology
Montreal Heart Institute/ Univeristy of Montreal
Montreal, Quebec, Canada

Disclosure information not submitted.

Disclosure(s):

Yoshinobu Onuma, MD, PhD: No financial relationships to disclose

Robert A. Byrne, MD, BCh, PhD: No financial relationships to disclose

Nicolas Foin, MSc, PhD: CoreAalst: Consulting Fees (e.g., advisory boards) (Ongoing), Executive Board (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Cezar A. Iliescu, MD: No financial relationships to disclose